Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor vs Prasugrel/Clopidogrel Effect on FFR
NCT02108808Phase 4Completed
- Sponsor
- University of Patras
- Start
- Apr 2014
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ticagrelor in coronary artery stenosis (2 arms), sponsored by University of Patras. Primary endpoint: Percent relative change in steady hyperemia Fractional Flow Reserve (sFFR) at 2 hours. Started Apr 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery stenosis
Beyond the preview
Go deeper on NCT02108808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02108808.